Legal & General Group
AMAM

Legal & General Group’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Legal & General Group’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,381
Closed -$15.9K – 3389
2023
Q3 		$15.9K Buy
+1,381
New +$15.9K ﹤0.01% 3118